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CytotoxicityAbstract In view of known antitumor and cytotoxic properties of 2- and 3-pyridinyl substituted
indole derivatives, respectively a number of isomeric N-pyridinyl substituted indoles and their ana-
logs were synthesized as potential cytotoxic agents. A greener approach was developed to synthesize
these compounds via an ultrasound assisted selective N  1 heteroarylation of indoles. The method-
ology involved reaction of indoles with heteroaryl halides in PEG-400 under ultrasound irradiation.
One of the products i.e. 1-(pyrimidin-2-yl)-1H-indole was further functionalized via Pd-mediated
CAH activation at C-2 on the indole ring. All the synthesized N  1 heteroarylindoles were tested
for their in vitro anti-proliferative properties against cancer (leukemia) and non-cancerous cell lines.
Some of the compounds showed promising and selective cytotoxic effects toward leukemia cells.
 2015 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The indole ring is considered as one of the most privileged structures
for the discovery of new bioactive molecules and drugs (Kaushik
et al., 2013). This is because compounds containing indole nucleusexhibit a wide range of pharmacological properties including antican-
cer activities (Saundane et al., 2014; Parrino et al., 2015a,b; Carbone
et al., 2015; Xie et al., 2015; Parrino et al., 2014a,b; Barraja et al.,
2012; Spano` et al., 2014). The pyridine nucleus on the other hand
has been found to be an integral part of many anti-cancer agents
(Abdou et al., 2014; Carbone et al., 2013; Spano` et al., 2015; Parrino
et al., 2014a,b). It is therefore not surprising that a combination of
both in a single molecular entity would show encouraging anticancer
activities. Indeed this is exemplified by promising antitumor activities
(Fan et al., 2011) of compound A and CDK inhibition as well as cyto-
toxic properties (Jacquemard et al., 2008) of compound B both of
which contain an indole and pyridine ring connected to each other
(Fig. 1). Notably, the pyridine ring is present at C-3 and C-2 position
of the indole ring in case of A and B respectively and compounds con-
taining a pyridine ring attached to the indole nitrogen have not beential anti-
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Scheme 1 Ultrasound assisted selective N  1 heteroarylation of
indoles.
2 E. Sailaja et al.studied for their pharmacological properties. Specifically, pharmaco-
logical evaluation of N-(het)aryl indole derivatives was not common
in the literature until 2011. However, in the same year potent antipro-
liferative activities of a series of N-(het)aryl-5,6,7-trimethoxyindoles
(C, Fig. 2) were reported and were derived from a known antimitotic
agent combretastatin A-4(CA4) (Lee et al., 2011).
All these observations and reports and our interest in indole deriva-
tives (Pal et al., 2004a,b; Rao et al., 2011; Nakhi et al., 2011; Gorja
et al., 2013; Dulla et al., 2014) prompted us to explore a series of
indoles possessing a pyridine or similar moiety at N  1 position for
their anti-proliferative properties against cancer cell lines. Herein we
report the synthesis and in vitro evaluation of a library of small mole-
cules based on D.
The selective N  1 arylation of indole ring can generally be per-
formed in a straightforward manner via Cu-catalyzed Ullmann-type
coupling reactions (Ullmann, 1903, 1904; Sambiagio et al., 2014).
However, several drawbacks involved with this classical cross-
coupling method greatly diminished its practical applications. This
includes the requirement of stoichiometric amount of a Cu catalyst,
high reaction temperature, etc. Thus subsequent efforts devoted to
improve the efficiency and utility of this process resulted in many
reports on transition metal mediated coupling strategies. Thus N  1
arylation of indoles was carried out under various conditions by using
aryl halides or aryl boronic acids in the presence of a transition metal
catalyst (Joucla and Djakovitch, 2009). In general the use of heteroge-
neous Cu-catalysts has gained particular attention and a large number
of reports have appeared in the literature (Djakovitch et al., 2011).
While several Cu-ligand combinations have been used to perform the
selective N  1 arylation of indole ring under comparatively mild con-
ditions the use of expensive ligands or the cumbersome preparation of
complex catalysts in some cases causes practical problems. Indeed,
efforts have been devoted to find simpler catalyst system that does
not require any ligand and the reaction can proceed in a green solvent
or under a solvent-free condition. Recently, in view of importance of
microwave irradiation in the context of green and sustainable chem-
istry and its known ability to accelerate the Cu-mediated CAN bond
forming reaction, a solvent and ligand free Cu-catalyzed coupling
between halopyridine and N-nucleophiles including indole under
microwave irradiation has been reported (Liu et al., 2011). Notably,
the coupling of activated heteroaryl halide with indole has been
reported in the absence of any catalyst and ligand (Xu et al., 2012;N
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Figure 2 Potent antiproliferative agents N-(het)aryl-5,6,7-
trimethoxyindoles (C) and the designed indole derivatives (D).
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ature and for a longer duration of time. We anticipated that this type
of coupling reaction can be accelerated by using ultrasound radiation
under mild conditions.
The ultrasound assisted organic reactions have attracted enormous
attention in recent time as adopting such strategies is considered as an
important step toward green chemistry. Indeed, the use of ultrasound
in organic reactions is beneficial in terms of energy conservation and
waste minimization compared to conventional heating. Moreover,
compared to the traditional methods the ultrasound assisted reactions
offer advantages such as shorter reaction time, milder conditions, and
higher yields of products (Li et al., 2005; Ratoarinoro et al., 1992).
Thus, it is not surprising that ultrasound assisted reactions have
emerged as a powerful technique in present day organic synthesis
(Cravotto and Cintas, 2006). Because of its non-hazardous nature,
easy recovery (from the reaction mixture) and recyclability, polyethy-
lene glycol 400 (PEG 400) on the other hand is considered as an envi-
ronment friendly solvent in various organic reactions (Chen et al.,
2005). Thus the use of inexpensive and obviously benign PEG often
offers significant green chemistry benefits. In view of considerable
advantages associated with the use of both ultrasound and PEG 400
we decided to explore the reaction of indoles (1) with heteroaryl halides
(2) in PEG 400 under ultrasound irradiation leading to the synthesis of
our target compounds (3) based on D (Scheme 1).
2. Material and methods
2.1. General methods
Unless stated otherwise, reactions were monitored by thin
layer chromatography (TLC) on silica gel plates (60 F254),
visualizing with ultraviolet light or iodine spray. Column chro-
matography was performed on silica gel (60–120 mesh) using
distilled petroleum ether and ethyl acetate. 1H and 13C NMR
spectra were determined in CDCl3 solution using a Varian
400 MHz spectrometer. Proton chemical shifts (d) are relative
to tetramethylsilane (TMS, d= 0.0) as internal standard and
expressed in parts per million. Spin multiplicities are given as
s (singlet), d (doublet), t (triplet), and m (multiplet) as well
as b (broad). Coupling constants (J) are given in hertz. Melting
points were determined by using a Buchi melting point B-540
apparatus. MS spectra were obtained on a Agilent 6430 series
Triple Quard LC-MS/MS spectrometer. HRMS was deter-
mined using waters LCT premier XETOF ARE-047
apparatus.
2.2. General method for the synthesis of N-heteroaryl substituted
indole derivatives 3
A solution of compound 1 (1.0 mmol), 2 (1.2 mmol) and Cs2-
CO3 (2.0 mmol) in PEG 400 (3 mL) was stirred at 25 C under
ultrasound (using a laboratory ultrasonic bath SONOREX
SUPER RK 510H model producing irradiation of 35 kHz)1 heteroarylation of indoles: Synthesis and in vitro evaluation of potential anti-
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tained at 25 C by adding cold water time to time. After com-
pletion of the reaction (indicated by TLC) the mixture was
diluted with cold water (60 mL) and extracted with EtOAc
(3  30 mL). The EtOAc layers were collected, combined,
washed with brine solution (2  30 mL) followed by cold
water, dried over anhydrous Na2SO4, filtered and concentrated
under low vacuum. The crude product isolated was purified by
column chromatography over silica gel using 2–5% hexane–
EtOAc as eluant.
2.2.1. 1-(Pyridin-2-yl)-1H-indole (3a) (Xu et al., 2012)
Pale yellow oil; 1H NMR (400 MHz, CDCl3): d 8.60 (d,
J= 4.0 Hz, 1H), 8.26 (d, J= 8.2 Hz, 1H), 7.82 (t,
J= 6.5 Hz, 1H), 7.76 (d, J= 3.4 Hz, 1H), 7.71 (d,
J= 7.8 Hz, 1H), 7.50 (d, J= 8.5 Hz, 1H), 7.35 (t,
J= 7.7 Hz, 1H), 7.26 (t, J= 7.3 Hz, 1H), 7.18 (m, 1H), 6.76
(d, J= 3.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 152.4,
148.8, 138.2, 135.1, 130.3, 126.0, 123.1, 121.1, 121.0, 120.0,
114.4, 113.0, 105.4; IR (KBr, cm1): 1593, 1521, 1471; MS
(ESI) m/z: 195 (M+, 100); HPLC: 98.5%, Column: Symmetry
C-18 75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1% TFA in
water, mobile phase B: CH3CN (T/%B): 0/20, 3/20, 8/40,
15/95, 20/95, 25/20, 30/20; flow rate: 1.0 mL/min; Diluent:
ACN: WATER (90:10).
2.2.2. 3-Methyl-1-(pyridin-2-yl)-1H-indole (3b) (Xu et al.,
2012)
Light yellow oil; 1H NMR (400 MHz, CDCl3): d 8.40 (m, 1H),
8.11 (d, J= 8.2 Hz, 1H), 7.61 (dt, J= 2.2 Hz, J= 8.6 Hz,
1H), 7.47 (m, 1H), 7.40 (d, J= 7.7 Hz, 1H), 7.31 (m, 1H),
7.23 (m, 1H), 7.11 (dt, J= 1.1 Hz, J= 7.4 Hz, 1H), 6.93 (m,
1H), 2.25 (s, 3H); 13C NMR (100 MHz, CDCl3): d 152.4,
148.6, 138.1, 135.2, 131.0, 123.1, 123.0, 120.7, 119.2, 119.0,
114.6, 113.7, 113.0, 9.5; IR (KBr, cm1): 1590, 1522, 1470;
MS (ESI) m/z: 209 (M+, 100); HPLC: 99.1%, Column: Sym-
metry C-18 75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1% TFA
in water, mobile phase B: CH3CN (T/%B): 0/20, 3/20, 8/40,
15/95, 20/95, 25/20, 30/20; flow rate: 1.0 mL/min; Diluent:
ACN: WATER (90:10).
2.2.3. 5-Methoxy-1-(pyridin-2-yl)-1H-indole (3c) (Xu et al.,
2012)
Pale yellow oil; 1H NMR (400 MHz, CDCl3): d 8.54 (d,
J= 4.0 Hz, 1H), 8.17 (d, J= 8.7 Hz, 1H), 7.80 (m, 1H),
7.69 (d, J= 3.4 Hz, 1H), 7.44 (d, J= 8.0 Hz, 1H), 7.13 (m,
2H), 6.94 (dd, J= 8.7 Hz, J= 1.8 Hz, 1H), 6.66 (d,
J= 3.8 Hz, 1H), 3.36 (s, 3H); 13C NMR (100 MHz, CDCl3):
d 155.0, 152.5, 148.8, 138.3, 131.1, 130.1, 126.2, 119.6, 114.1,
113.8, 112.6, 105.3, 103.0, 55.7; IR (KBr, cm1): 1593, 1478,
1436; MS (ESI) m/z: 225 (M+, 100); HPLC: 97.8%, Column:
Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1%
TFA in water, mobile phase B: CH3CN (T/%B): 0/20, 3/20,
8/40, 15/95, 20/95, 25/20, 30/20; flow rate: 1.0 mL/min; Dilu-
ent: ACN: WATER (90:10).
2.2.4. 6-Methyl-1-(pyridin-2-yl)-1H-indole (3d) (Xu et al.,
2012)
Pale yellow oil; 1H NMR (400 MHz, CDCl3): d 8.59 (dd,
J= 4.7 Hz, J= 1.0 Hz, 1H), 8.16 (d, J= 8.5 Hz, 1H), 7.80Please cite this article in press as: Sailaja, E. et al., A greener approach toward N 
proliferative agents. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016(m, 1H), 7.74 (d, J= 3.3 Hz, 1H), 7.49 (br, 2H), 7.16 (m,
2H), 6.68 (d, J= 3.3 Hz, 1H), 2.53 (s, 3H); 13C NMR
(100 MHz, CDCl3): d 152.4, 148.7, 138.1, 133.2, 130.6, 130.4,
125.7, 124.4, 120.7, 120.0, 114.0, 112.6, 105.0, 21.2; IR (KBr,
cm1): 1592, 1475, 1470; MS (ESI) m/z: 209 (M+, 100); HPLC:
97.4%, Column: Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile
phase A: 0.1% TFA in water, mobile phase B: CH3CN (T/%
B): 0/20, 3/20, 8/40, 15/95, 20/95, 25/20, 30/20; flow rate:
1.0 mL/min; Diluent: ACN: WATER (90:10).
2.2.5. 5-Chloro-1-(pyridin-2-yl)-1H-indole (3e) (Xu et al.,
2012)
Gummy mass; 1H NMR (400 MHz, CDCl3): d 8.58 (m, 1H),
8.22 (d,J= 8.7 Hz, 1H), 7.83 (d, J= 6.7 Hz, J= 1.4 Hz,
1H), 7.72 (d, J= 3.3 Hz, 1H), 7.63 (d, J= 2.0 Hz, 1H), 7.45
(d, J= 8.1 Hz, 1H), 7.26 (dd, J= 8.7 Hz, J= 1.8 Hz, 1H),
7.19 (dd, J= 7.0 Hz, J= 4.4 Hz, 1H), 6.66 (d, J= 3.8 Hz,
1H); 13C NMR (100 MHz, CDCl3): d 152.2, 149.0, 138.4,
133.5, 131.4, 127.0, 126.7, 123.2, 120.3, 120.2, 114.3, 114.2,
105.0; IR (KBr, cm1): 1589, 1516, 1471; MS (ESI) m/z: 229
(M+, 100); HPLC: 95.9%, Column: Symmetry C-18
75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1% TFA in water,
mobile phase B: CH3CN (T/%B): 0/20, 3/20, 8/40, 15/95,
20/95, 25/20, 30/20; flow rate: 1.0 mL/min; Diluent: ACN:
WATER (90:10).
2.2.6. 3-Methyl-1-(4-methylpyridin-2-yl)-1H-indole (3f)
Gummy mass; 1H NMR (400 MHz, CDCl3): d 8.41 (s, 1H),
8.24 (d, J= 8.3 Hz, 1H), 7.68 (d, J= 7.7 Hz, 1H), 7.56 (d,
J= 6.3 Hz, 1H), 7.53 (s, 1H), 7.32 (m, 3H), 2.45 (s, 3H),
2.38 (s, 3H); 13C NMR (100 MHz, CDCl3): d 150.4, 148.8,
139.0, 135.3, 130.8, 129.0, 123.4, 123.0, 120.5, 119.0, 114.1,
113.7, 112.8, 17.7, 9.7; MS (ESI) m/z: 223 (M+, 100); HPLC:
98.7%, Column: Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile
phase A: 0.1% TFA in water, mobile phase B: CH3CN (T/%
B): 0/20, 3/20, 8/40, 15/95, 20/95, 25/20, 30/20; flow rate:
1.0 mL/min; Diluent: ACN: WATER (90:10); HRMS m/z
(ESI) Calcd for C15H14N2Na (M+Na)
+, 245.1049, found
245.1044.
2.2.7. 3-Methyl-1-(5-methylpyridin-2-yl)-1H-indole (3g)
Gummy mass; 1H NMR (400 MHz, CDCl3): d 8.41 (dd,
J= 11.7 and 6.3 Hz, 1H), 8.26 (dd, J= 11.7 and 7.0 Hz,
1H), 7.63 (d, J= 7.4 Hz, 1H), 7.53 (s, 1H), 7.34 (m, 1H),
7.27 (m, 3H), 6.95 (d, J= 8.1 Hz, 1H), 2.42 (s, 3H), 2.41 (s,
3H); 13C NMR (100 MHz, CDCl3): d 152.7, 149.5, 148.4,
135.3, 131.0, 123.3, 123.0, 120.7, 120.6, 119.0, 114.6, 114.4,
113.0, 21.2, 9.6; MS (ESI) m/z: 223 (M+, 100); HPLC:
96.3%, Column: Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile
phase A: 0.1% TFA in water, mobile phase B: CH3CN (T/%
B): 0/20, 3/20, 8/40, 15/95, 20/95, 25/20, 30/20; flow rate:
1.0 mL/min; Diluent: ACN: WATER (90:10); HRMS (ESI)
Calcd for C15H14N2Na (M+Na)
+, 245.1049, found
245.1053.
2.2.8. 5-Methyl-1-(5-methylpyridin-2-yl)-1H-indole (3h)
Gummy mass; 1H NMR (400 MHz, CDCl3): d 8.25 (d,
J= 1.6 Hz, 1H), 7.91 (d, J= 8.3 Hz, 1H), 7.55 (d,
J= 3.3 Hz, 1H), 7.46 (dd, J= 8.3 and 1.9 Hz, 1H), 7.33 (s,
1H), 7.24 (d, J= 8.3 Hz, 1H), 7.00 (d, J= 8.5 Hz, 1H), 6.501 heteroarylation of indoles: Synthesis and in vitro evaluation of potential anti-
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4 E. Sailaja et al.(d, J= 3.4 Hz, 1H), 2.36 (s, 3H), 2.24 (s, 3H); 13C NMR
(100 MHz, CDCl3): d 150.4, 149.0, 138.8, 133.3, 130.5, 130.2,
129.2, 126.0, 124.4, 120.7, 114.0, 112.3, 104.6, 21.3, 17.7; MS
(ESI) m/z: 223 (M+, 100); HPLC: 98.9%, Column: Symmetry
C-18 75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1% TFA in
water, mobile phase B: CH3CN (T/%B): 0/20, 3/20, 8/40,
15/95, 20/95, 25/20, 30/20; flow rate: 1.0 mL/min; Diluent:
ACN: WATER (90:10); HRMS (ESI) Calcd for C15H14N2Na
(M+Na)+, 245.1049, found 245.1040.
2.2.9. 5-Chloro-1-(5-methylpyridin-2-yl)-1H-indole (3i)
Gummy mass; 1H NMR (400 MHz, CDCl3): d 8.30 (dd,
J= 1.5 and 0.6 Hz, 1H), 8.01 (d, J= 8.8 Hz, 1H), 7.59 (d,
J= 3.4 Hz, 1H), 7.55 (dd, J= 7.8, 2.0 Hz, 1H), 7.53
(d, J= 2.0 Hz, 1H), 7.26 (d, J= 8.2 Hz, 1H), 7.14 (dd,
J= 8.8 and 2.2 Hz, 1H), 6.55 (dd, J= 3.4 and 0.6 Hz, 1H),
2.31 (s, 3H); 13C NMR (100 MHz, CDCl3): d 150.0, 148.0,
139.0, 133.4, 131.1, 130.0, 127.1, 126.5, 123.0, 120.3, 114.0,
113.9, 104.4, 17.7; MS (ESI) m/z: 243 (M+, 100); HPLC:
96.8%, Column: Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile
phase A: 0.1% TFA in water, mobile phase B: CH3CN (T/%
B): 0/20, 3/20, 8/40, 15/95, 20/95, 25/20, 30/20; flow rate:
1.0 mL/min; Diluent: ACN: WATER (90:10); HRMS
(ESI) Calcd for C14H11N2ClNa (M+Na)
+, 265.0503, found
265.0549.
2.2.10. 5-Methoxy-1-(5-methylpyridin-2-yl)-1H-indole (3j)
Low melting solid; 1H NMR (400 MHz, CDCl3): d 8.28 (dd,
J= 1.5 and 0.5 Hz, 1H), 8.00 (d, J= 9.0 Hz, 1H), 7.59 (d,
J= 3.3 Hz, 1H), 7.52 (dd, J= 8.4 and 2.3 Hz, 1H), 7.03 (d,
J= 2.4 Hz, 1H), 6.84 (dd, J= 9.0 and 2.5 Hz, 1H), 6.53 (d,
J= 3.1 Hz, 1H), 3.79 (s, 3H), 2.29 (s, 3H); 13C NMR
(100 MHz, CDCl3): d 154.8, 150.3, 148.8, 138.8, 130.8, 130.1,
129.2, 126.3, 113.7, 112.5, 104.7, 102.8, 55.7, 17.7; MS (ESI)
m/z: 239 (M+, 100); HPLC: 96.3%, Column: Symmetry C-
18 75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1% TFA in water,
mobile phase B: CH3CN (T/%B): 0/20, 3/20, 8/40, 15/95,
20/95, 25/20, 30/20; flow rate: 1.0 mL/min; Diluent: ACN:
WATER (90:10); HRMS (ESI) Calcd for C15H14N2ONa (M
+Na)+, 261.0998, found 261.0993.
2.2.11. 5-Fluoro-1-(5-methylpyridin-2-yl)-1H-indole (3k)
Low melting solid; 1H NMR (400 MHz, CDCl3): d 8.26 (s,
1H), 8.03 (dd, J= 9.0 and 4.5 Hz, 1H), 7.57 (t, J= 3.0 Hz,
1H), 7.49 (t, J= 5.6 Hz, 1H), 7.21 (m, 2H), 6.91 (t,
J= 9.4 Hz, 1H), 6.54 (m, 1H), 2.26 (s, 3H); 13C NMR
(100 MHz, CDCl3): d 158.3 (JCF = 236 MHz), 150.2, 148.8,
139.0, 131.6, 130.7 (JCF = 10 MHz), 129.7, 127.3, 114.0,
113.8, 111.0 (JCF = 26 MHz), 105.7 (JCF = 23 MHz), 104.7
(JCF = 4 MHz), 17.7; MS (ESI) m/z: 227 (M
+, 100); HPLC:
97.1%, Column: Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile
phase A: 0.1% TFA in water, mobile phase B: CH3CN (T/%
B): 0/20, 3/20, 8/40, 15/95, 20/95, 25/20, 30/20; flow rate:
1.0 mL/min; Diluent: ACN: WATER (90:10); HRMS (ESI)
Calcd for C14H11N2FNa (M+Na)
+, 249.0798, found
249.0791.
2.2.12. 3-Methyl-1-(6-methylpyridin-2-yl)-1H-indole (3l)
Gummy mass; 1H NMR (400 MHz, CDCl3): d 8.17 (d,
J= 8.3 Hz, 1H), 7.58 (t, J= 8.0 Hz, 1H), 7.52 (d,Please cite this article in press as: Sailaja, E. et al., A greener approach toward N 
proliferative agents. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016J= 7.7 Hz, 1H), 7.44 (d, J= 1.0 Hz, 1H), 7.22 (t,
J= 8.9 Hz, 1H), 7.15 (m, 2H), 6.89 (d, J= 7.4 Hz, 1H),
2.54 (s, 3H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3): d
158.0, 152.0, 138.3, 135.3, 131.0, 123.2, 123.0, 120.5, 119.0,
118.7, 114.3, 113.1, 110.7, 24.3, 9.5; MS (ESI) m/z: 223 (M+,
100); HPLC: 97.7%, Column: Symmetry C-18 75 * 4.6 mm,
3.5 lm, mobile phase A: 0.1% TFA in water, mobile phase
B: CH3CN (T/%B): 0/20, 3/20, 8/40, 15/95, 20/95, 25/20,
30/20; flow rate: 1.0 mL/min; Diluent: ACN: WATER
(90:10); HRMS (ESI) Calcd for C15H14N2Na (M+Na)
+,
245.1049, found 245.1054.
2.2.13. 1-(Pyrimidin-2-yl)-1H-indole (3m) (Ackermann and
Lygin, 2011)
Off white solid; mp 65–67 C [lit 85–86 C (Ackermann and
Lygin, 2011)]; 1H NMR (400 MHz, CDCl3): d 8.82 (d,
J= 8.4 Hz, 1H), 8.69 (d, J= 4.4 Hz, 2H), 8.28 (d,
J= 3.4 Hz, 1H), 7.63 (d, J= 8.0 Hz, 1H), 7.37–7.34 (m,
1H), 7.28–7.23 (m, 1H), 7.04–7.01 (m, 1H), 6.71 (d,
J= 3.4 Hz, 1H). 13C NMR (100 MHz, CDCl3): d 158.0,
157.7, 135.3, 131.3, 125.8, 123.6, 122.1, 120.8, 116.3, 116.0,
107.0; IR (KBr, cm1): 1576, 1524, 1454, 1305; MS (ESI) m/
z: 196 (M+, 100); HPLC: 98.1%, Column: Symmetry C-18
75 * 4.6 mm, 3.5 lm, mobile phase A: 0.1% TFA in water,
mobile phase B: CH3CN (T/%B): 0/20, 1/20, 4/98, 10/98,
10.5/20, 12/20; flow rate: 1.0 mL/min; Diluent: ACN: WATER
(90:10).
2.3. 5-Methoxy-1-(pyrimidin-2-yl)-1H-indole (3n)
(Ackermann and Lygin, 2011)
Ash colored solid; mp 109–110 C [109–110 C (Ackermann
and Lygin, 2011)]; 1H NMR (CDCl3, 400 MHz): d 8.69 (d,
J= 9.0 Hz, 1H), 8.64 (d, J= 5.0 Hz, 2H), 8.24 (d,
J= 3.4 Hz, 1H), 7.09 (d, J= 2.4 Hz, 1H), 6.98–6.96 (m,
2H), 6.63 (d, J= 3.4 Hz, 1H), 3.88 (s, 3H); 13C NMR (CDCl3,
100 MHz): d 158.1, 157.6, 155.5, 132.1, 130.3, 126.3, 117.1,
116.0, 112.6, 106.8, 103.1, 55.7; IR (KBr, cm1): 1578,
15,256 1453; MS (ESI) m/z: 226 (M+, 100); HPLC: 95.9%,
Column: Symmetry C-18 75 * 4.6 mm, 3.5 lm, mobile phase
A: 0.1% TFA in water, mobile phase B: CH3CN (T/%B):
0/20, 1/20, 4/98, 10/98, 10.5/20, 12/20; flow rate: 1.0 mL/min;
Diluent: ACN: WATER (90:10).
2.4. 5-Bromo-1-(pyrimidin-2-yl)-1H-indole (3o)
Off white solid; mp 101–103 C; 1H NMR (CDCl3,
400 MHz): d 8.70 (d, J= 5.0 Hz, 2H), 8.67 (s, 1H), 8.27
(d, J= 4.0 Hz, 1H), 7.73 (d, J= 2.0 Hz, 1H), 7.41 (dd,
J= 9.0 and 2.0 Hz, 1H), 7.06 (t, J= 5.0 Hz, 1H), 6.62
(d, J= 3.0 Hz, 1H); 13C NMR (CDCl3, 100 MHz): d
158.2, 157.5, 134.0, 133.0, 127.1, 126.4, 123.4, 117.8,
116.5, 115.4, 106.1; IR (KBr, cm1): 1579, 1522, 1455;
MS (ESI) m/z: 274 (M+, 100), 276 (M+ 2); HPLC:
97.5%, Column: X-Terra RP18 250  4.6 mm 5.0 lm,
mobile phase A: 0.1% TFA in water, mobile phase B:
CH3CN, gradient (T/%B): 0/20, 3/20, 12/95, 23/95, 25/20,
30/20; flow rate: 1.0 mL/min; Diluent: ACN: WATER
(90:10); HRMS (ESI) Calcd for C12H8BrN3Na
(M+Na)+, 295.9799, found 295.9791.1 heteroarylation of indoles: Synthesis and in vitro evaluation of potential anti-
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Table 1 The effect of conditions on the reaction of 1a with
2a.a
N
N
3a
N
H
+
N
Br
base
solvent
1a 2a
Entry Base Solvent Time (h) % Yieldb
1. Na2CO3 DMSO 2 39
2. K2CO3 DMSO 2 42
3. Cs2CO3 DMSO 2 61
4. Cs2CO3 DMSO 12 17
c
5. Cs2CO3 PEG 400 2 69
6. Cs2CO3 PEG 400 6 70
7. Cs2CO3 PEG 400 2 71
d
8. – PEG 400 2 0
a All the reactions were performed using 1a (1 mmol), 2a
(1.2 mmol) and a base (2 mmol) in a solvent (3 mL) at 25 C under
ultrasound irradiation as well as open air.
b Isolated yield.
c The reaction was performed in the absence of ultrasound.
d The reaction was performed at 50 C instead of 25 C.
A greener approach towards heteroarylation of indoles 52.5. Preparation of phenyl(1-(pyrimidin-2-yl)-1H-indol-2-yl)
methanone (5) (Kumar and Sekar, 2015)
A mixture of indole 3m (1.0 mmol), benzaldehyde 4
(1.5 mmol), PdCl2 (0.10 mmol), and TBHP (3.0 mmol) in
toluene (4 mL) was heated at 90 C in a reaction tube for
12 h. After completion of the reaction (indicated by TLC)
the mixture was cooled to room temperature, treated with
EtOAc (50 mL), and washed with saturated NaHCO3 solution
(2  20 mL). The organic layer was collected, dried
over anhydrous Na2SO4, filtered and concentrated under
reduced pressure. The residue thus obtained was purified by
column chromatography over silica gel using 2–5%
EtOAc-hexane as eluant to give the desired product; white
solid; yield 76%; mp 122–123 C; 1H NMR (400 MHz, CDCl3)
d 8.64 (d, J= 4.3 Hz, 2H), 8.42 (d, J= 8.3, 1H), 7.9 (d,
J= 7.5 Hz, 2H), 7.72 (d, J= 7.9 Hz, 1H), 7.62–7.52 (m,
1H), 7.46–7.44 (m, 3H), 7.35–7.27 (m, 1H), 7.14 (s, 1H),
7.07–7.05 (m, 1H); 13C NMR (100 MHz, CDCl3) d 187.6,
158.0, 157.3, 138.3, 138.0, 137.2, 132.7, 129.5, 128.3, 128.0,
126.5, 122.8, 122.5, 117.3, 115.4, 114.3; MS (ESI) m/z: 300.1
(M+, 100).
2.6. Preparation of (1H-indol-2-yl)(phenyl)methanone (6)
(Kumar and Sekar, 2015)
A solution of compound 5 (0.8 mmol) and sodium ethoxide (6
equiv.) in DMSO (10 mL) was stirred under nitrogen at room
temperature for 5 min and then at 100 C for 12 h. After com-
pletion of the reaction (indicated by TLC) the mixture was
diluted with water (60 mL) and extracted with EtOAc. The
organic layers were collected, combined, washed with brine,
dried over anhydrous Na2SO4, filtered and concentrated under
low vacuum. The residue obtained was purified by column
chromatography over silica gel using 2–5% EtOAc–hexane
as eluant to give the desired product; off white solid; yield
71%; mp 147–149 C; 1H NMR (400 MHz, CDCl3) d 9.54
(bs, 1H), 8.09–7.97 (m, 2H), 7.72 (d, J= 8.0 Hz, 1H), 7.66–
7.60 (m, 1H), 7.58–7.46 (m, 3H), 7.41–7.34 (m, 1H), 7.20–
7.13 (m, 2H); 13C NMR (100 MHz, CDCl3) d 187.3, 138.1,
137.6, 134.5, 132.4, 129.3, 128.5, 127.8, 126.6, 123.3, 121.1,
113.0, 112.3; MS (ESI) m/z: 221.7 (M+, 100).
2.7. Pharmacology
2.7.1. Cell lines and culture conditions
Human chronic myeloid leukemia cells, K562, human colon
carcinoma cells, Colo-205, and human embryonic kidney cells,
HEK293, were procured from National Center for
Cell Sciences, Pune, India. All cells were grown in
RPMI-1640 supplemented with 10% heat inactivated fetal
bovine serum (FBS), 100 IU/ml penicillin, 100 mg/ml strepto-
mycin and 2 mM-glutamine. Cultures were maintained in a
humidified atmosphere with 5% CO2 at 37 C. The cells were
subcultured twice each week, seeding at a density of about
2  103 cells/ml.
2.7.2. MTT assay
Cell viability was determined by 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay. Cells (5  103Please cite this article in press as: Sailaja, E. et al., A greener approach toward N 
proliferative agents. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016cells/well) were seeded to 96-well culture plate and cultured
with or without compounds at 10 lM concentration (five dif-
ferent concentrations i.e., 10, 5, 1, 0.5, 0.1 and 0.01 lM for
dose response study) in duplicates for 24 h in a final
volume of 200 ll. After treatment, the medium was removed
and 20 ll of MTT (5 mg/ml in PBS) was added to the
fresh medium. After 3 h incubation at 37 C, 100 ll of DMSO
was added to each well and plates were agitated for 1 min.
Absorbance was read at 570 nm on a multi-well plate
reader (Victor3, Perkin Elmer). Percent inhibition of prolifera-
tion was calculated as a fraction of control (without
compound).
3. Results and discussion
3.1. Chemistry
In order to establish the optimal reaction conditions the reac-
tion of indole (1a) with 2-bromopyridine (2a) was performed
under various conditions. Initially, the reaction was performed
at room temperature in the presence of Na2CO3 in DMSO
under ultrasound irradiation using a laboratory ultrasonic
bath SONOREX SUPER RK 510H model producing irradia-
tion of 35 kHz. The reaction proceeded under this condition
affording the desired product 3a albeit in low yield (entry 1,
Table 1). Though replacing Na2CO3 with K2CO3 did not
improve the yield significantly (entry 2, Table 1) the use of Cs2-
CO3 afforded 3a in 61% yield (entry 3, Table 1). We were
pleased with this observation that prompted us to investigate
the reaction further. To know the role of ultrasound in this
CAN bond forming reaction the reaction of 1a with 2a was
performed in the absence of any ultrasound irradiation. The1 heteroarylation of indoles: Synthesis and in vitro evaluation of potential anti-
/j.arabjc.2015.11.008
Table 2 Synthesis of N-heteroaryl substituted indole derivatives (3).a
N
Y N
R1
R2
R3
3
N
H
R1
R2 + Y
N
R3
X
Cs2CO3, PEG-400
room temp
1 2
Entry Indole 1 Heteroaryl halide 2 Time (h) Product 3 % yieldb
1.
N
H 1a 
NBr
2a
2
N
N
3a 
69
2. NH 1b 2a 2.5
N
N
3b 
67
3.
N
H
MeO
1c 2a 2.5 N
N
MeO
3c 
65
4.
N
H 1d 2a 2.5
N
N
3d 
67
5.
N
H
Cl
1e 2a 2
N
N
Cl
3e 
72
6. 1b
NBr
2b 2.5 N
N
3f 
69
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Table 2 (continued)
Entry Indole 1 Heteroaryl halide 2 Time (h) Product 3 % yieldb
7. 1b
NBr
2c
2.5
N
N
3g 
67
8.
N
H 1f 
2c 2.5
N
N
3h 
69
9. 1e 2c 2
N
N
Cl
3i 
73
10. 1c 2c 2.5
N
N
MeO
3j 
64
11.
N
H
F
1g
2c 2
N
N
F
3k 
76
12. 1b
NBr
2d
2 N
N
 3l 
69
13. 1a
N
NCl
2e
2
N
N
N
3m 
77
(continued on next page)
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Table 2 (continued)
Entry Indole 1 Heteroaryl halide 2 Time (h) Product 3 % yieldb
14. 1c 2e 2
N
N
N
MeO
 3n 
69
15.
N
H
Br
1h 2e 2
N
N
N
Br
 3o 
70
a All the reactions were performed using 1 (1 mmol), 2 (1.2 mmol) and Cs2CO3 (2.0 mmol) in PEG 400 (3 mL) at 25 C for 2–2.5 h under
ultrasound irradiation as well as open air.
b Isolated yield.
8 E. Sailaja et al.product 3a was isolated in poor yield after 12 h (entry 4,
Table 1) indicating that ultrasound played a key role in the
present reaction. While DMSO was found to be an effective
solvent for the present ultrasound assisted reaction there was
a need to improve the yield of 3a further. Fortunately, an
improvement in yield of 3a was observed when the reaction
was performed in PEG 400 for 2 h (entry 5, Table 1). However,
no further increase in yield was observed when the reaction
was performed for a longer time or at elevated temperature
(entry 6 and 7, Table 1). The reaction did not proceed in the
absence of a base (entry 8, Table 1). While the reaction pro-
ceeded in the absence of ultrasound in PEG 400 the duration
of reaction was increased considerably i.e. to 12 h. Thus, the
condition of entry 5 was found to be milder as well as optimal
and used for further study.
Having established the optimal condition for the selective
N  1 heteroarylation of indole it was necessary to expand
the generality and scope of this reaction. Thus several indoles
(1a–h) were treated with a range of heteroaryl halides (2a–e)
under the optimized reaction conditions (Table 2). The reac-
tion proceeded well in all these cases affording good yields
of desired products 3a–o. Groups such as Me, OMe, F, Cl
and Br on the indole ring were well tolerated under the condi-
tions examined. Notably, though marginal better yields of
products were obtained when F, Cl and Br substituents were
present on the indole ring (entries 5, 9, 11 and 15, Table 2).
Generally, bromo heteroarenes (2a–c) were used as halide reac-
tants in the present ultrasound assisted CAN bond forming
reaction. The use of a chloro derivative i.e. 2e was also exam-
ined and was successful (entries 13–15, Table 2). One of theN
N
N
PhCHO+
PdCl2
TBHP, toluene
90 oC, 12h
76%3m 4 5
Scheme 2 Synthesis of 2-benzoyl indole (6) v
Please cite this article in press as: Sailaja, E. et al., A greener approach toward N 
proliferative agents. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016products i.e. 3m obtained via this reaction was functionalized
further according to a known method. Thus the reaction of
3m with benzaldehyde (4) in the presence of 10 mol% of PdCl2
and TBHP (tert-Butyl hydroperoxide) in toluene at 90 C
afforded the corresponding 2-acylated product 5 in good yield
(Scheme 2) (Kumar and Sekar, 2015; Yan et al., 2014; Li et al.,
2015a,b; Wang et al., 2015). The reaction proceeded via a Pd-
mediated direct CAH functionalized at C-2 of the indole ring
where the pyrimidine ring acted as a C(sp2)AH directing
group. This group was easily removed by using EtONa in
DMSO to afford the desired 2-benzoyl indole (6) (Scheme 2).
A probable mechanism for the selective N  1 heteroaryla-
tion of indoles under ultrasound irradiation is shown in
Scheme 3. The CAN bond forming reaction seemed to proceed
via activation of the halide substituent of AN‚C(X)A moiety
of 1. The solvent PEG 400 appeared to play the role of reac-
tion medium as well as an activating agent in the present reac-
tion under the condition employed [indeed the dual role of
PEG as a solvent and phase-transfer catalyst (PTC) is known]
(Totten et al., 1998; Totten and Clinton, 1988). Thus, H-bond
formation of the azomethine nitrogen [AN‚C(X)A] of 2 with
PEG 400 facilitated a nucleophilic attack at the adjacent halo-
gen bearing carbon atom of E-1. Deprotonation of indole 1
afforded the required nucleophile E-2 in situ that on reaction
with E-1 afforded E-3. Subsequent departure of halide ion
(in the form of CsX) from E-3 generated E-4 that released
PEG 400 to complete the reaction cycle along with the gener-
ation of desired product 3. Though it is not clear whether all or
any particular step was facilitated by the ultrasound irradia-
tion, the ultrasound might have played a role in the generationN
N
N
Ph
O
EtONa
DMSO
100 oC, 12h
71%
N
H
Ph
O
6
ia Pd-catalyzed direct C2-acylation of 3m.
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NR1
R2
Y N
R3
X
HO(CH2CH2O)nH
1
2
O(CH2CH2O)nH
H
Y N
R3
X
O(CH2CH2O)nH
H
Y N
R3
O(CH2CH2O)nH
HN
R1
R2
X
X
Y N
R3
O(CH2CH2O)nH
HN
R1
R2
3
(PEG-400) E-1
E-2
E-3E-4
Cs2CO3
Scheme 3 Proposed reaction mechanism for the N  1 heteroarylation of indoles (1) under ultrasound irradiation leading to 3.
Table 3 In vitro antiproliferative properties of compounds 3 against cancer and non-cancerous cells.a
N
Y
N
R1
R2
R3
Compounds R1, R2, R3 % Inhibition of cell growth @ 10 lM
K562 Leukemia Colo-205 Colon HEK293b non-cancerous
3a; H, H, H, CH 21.9 ± 1.12 17.1 ± 1.91 0.2
3b; 3-Me, H, H, CH 33.6 ± 1.20 18.6 ± 0.98 0.2
3c; H, 5-MeO, H, CH 68.8 ± 1.31 20.9 ± 1.83 2.1
3d; H, 6-Me, H, CH 21.7 ± 2.33 21.5 ± 1.85 0.4
3e; H, 5-Cl, H, CH 41.5 ± 1.42 18.4 ± 2.11 0.9
3f; 3-Me, H, 4-Me, CH 31.8 ± 3.09 13.1 ± 1.23 2.6
3g; 3-Me, H, 5-Me, CH 30.0 ± 2.10 22.1 ± 2.01 1.8
3h; H, 5-Me, 5-Me, CH 36.2 ± 2.19 18.9 ± 3.03 0.5
3i; H, 5-Cl, 5-Me, CH 39.4 ± 4.35 20.4 ± 2.07 2.1
3j; H, 5-MeO, 5-Me, CH 68.7 ± 3.45 24.9 ± 1.99 1.3
3k; H, 5-F, 5-Me, CH 39.9 ± 2.21 19.2 ± 2.21 0.7
3l; 3-Me, H, 6-Me, CH 25.3 ± 2.11 21.1 ± 1.15 1.9
3m; H, H, H, N 26.3 ± 3.10 10.9 ± 1.21 0.6
3n; H, 5-MeO, H, N 70.1 ± 2.40 37.5 ± 2.20 2.0
3o; H, 5-Br, H, N 28.5 ± 2.99 16.9 ± 1.84 0.9
a Data represent the mean values of three independent determinations.
b HEK293 cell line was used as noncancerous cell line.
A greener approach towards heteroarylation of indoles 9of anion E-2 (the deprotonation step), its reaction with E-1
(CAN bond formation step) and departure of leaving group
from E-3 (the aromatization step). It is to be noted that the
reaction also proceeded well in DMSO (Entry 3, Table 1) that
unlike PEG 400 was not an H-bond forming agent. However,
since dry DMSO was not used in the test reaction, the contam-Please cite this article in press as: Sailaja, E. et al., A greener approach toward N 
proliferative agents. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016inated moisture might have played the role of activating
agent via formation of H-bond with 2a thereby facilitating
the reaction. This was further supported by the fact that the
reaction of 1a with 2a in the presence of Cs2CO3 did not pro-
ceed well when performed in dry DMSO affording 3a in 38%
yield.1 heteroarylation of indoles: Synthesis and in vitro evaluation of potential anti-
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The synthesized compounds were tested for their anti-cancer
properties in vitro. The cells used for our in vitro studies include
human chronic myeloid leukemia cells i.e. K562, human colon
carcinoma cells i.e. Colo-205, and non-cancerous human
embryonic kidney cells i.e. HEK293. The effect of test com-
pounds on cell viability was measured using a colorimetric
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide] assay after 24 h of treatment in culture medium con-
taining PBS. The percentage inhibition of cell growth for com-
pounds at 10 lM is presented in Table 3. It is evident from
Table 3 that compound 3c, 3j and 3n showed promising activ-
ities against K562 cells whereas compound 3e, 3i and 3k
showed moderate activities. Except the compound 3n none
of these compounds showed significant activities against
Colo-205 cells. These observations suggested that a substituent
such as MeO, Cl, or F at C-5 position of the indole ring was
beneficial for the activity against K562 cells among which
MeO was found to be the best with the order MeO > Cl > F.
Additionally, none of these compounds showed any effect
when tested against non-cancerous HEK293 cells indicating
their selectivity toward cancer cells especially leukemia. In
the view of enormous importance in the identification of new
antileukemic agents the present class of molecules is of further
interest.4. Conclusion
In conclusion, a series of isomeric N-pyridinyl substituted indoles and
their analogs were designed as potential cytotoxic agents. A greener
approach was developed to synthesize these compounds via an ultra-
sound assisted selective N  1 heteroarylation of indoles. The
methodology involved reaction of indoles with heteroaryl halides in
PEG 400 under ultrasound irradiation. The reaction proceeded well
under the condition employed and afforded the desired products in
good yields with relatively shorter reaction time. The PEG 400
appeared to play a dual role i.e. the role of a solvent and promoting
agent in the present CAN bond forming reaction. One of the prod-
ucts i.e. 1-(pyrimidin-2-yl)-1H-indole was acylated at C-2 position
of the indole ring via a Pd-mediated CAH activation methodology.
All the synthesized N  1 heteroarylindoles were tested for their
in vitro anti-proliferative properties against cancer (e.g. leukemia
and colon) and non-cancerous cell lines. Some of the compounds
showed promising and selective cytotoxic effects toward leukemia
cells. The methodology presented here could be an alternative
method for the quicker access to a library of compounds based on
N-heteroaryl indole framework. Moreover, our study indicated that
this framework could be a potential template for the identification
of new antileukemic agents.
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